MEDICINES DISCOVERY CATAPULT LIMITED
Buyer information published with procurement notices.
- Published identifier
- GB-COH 09928547
- Address
- Macclesfield, UKD62, SK10 4ZF, United Kingdom
- First notice
- 17 Jun 2025
- Latest notice
- 5 Aug 2026
Published procurement activity · 30 tenders
Buyer information published with procurement notices.
MDC is seeking to procure a hot cell system, including design (where required), manufacture, supply, delivery, installation, commissioning, validation, and associated training and documentation. The solution may comprise an existing off-the-shelf product or a bespoke system, depending on the supplier's proposed technical solutio
MDC requires high level solution requirements for the replacement of Financial Management and Project Management & Resourcing systems. Suppliers who meet the requirements are invited to submit responses in accordance with this published invitation to tender (ITT). The tender will be published in 2 lots: • Lot 1: Financial Manage
PACE (Pathways to Antimicrobial Clinical Efficacy) is a £30 million initiative supporting and funding early-stage innovation in medicines and diagnostics, aimed at tackling AMR. It was established in September 2023 and is a collaboration between Innovate UK (IUK), LifeArc, and Medicines Discovery Catapult (MDC) - three leaders i
Medicines Discovery Catapult (MDC) is an independent, not-for-profit innovation centre for drug discovery and part of the Catapult Network established by Innovate UK. MDC's vision is to reshape drug discovery for patient benefit by transforming great UK science into better treatments through partnership. It supports drug discov
Organisation details and tender classifications reflect information published by the original procurement sources. Similar buyer names are grouped only where an official identifier or compatible name and postcode provide a safe link.